Agilent Technologies, Inc. $A Position Increased by Keybank National Association OH

Keybank National Association OH raised its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 24.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 28,153 shares of the medical research company’s stock after purchasing an additional 5,578 shares during the period. Keybank National Association OH’s holdings in Agilent Technologies were worth $3,831,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in A. Board of the Pension Protection Fund bought a new position in shares of Agilent Technologies during the fourth quarter valued at approximately $27,000. Davis Capital Management bought a new position in shares of Agilent Technologies during the third quarter valued at approximately $28,000. Physician Wealth Advisors Inc. grew its position in shares of Agilent Technologies by 490.0% during the third quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock worth $30,000 after acquiring an additional 196 shares during the last quarter. Torren Management LLC bought a new position in shares of Agilent Technologies during the fourth quarter worth about $32,000. Finally, State of Wyoming bought a new position in shares of Agilent Technologies during the second quarter worth about $35,000.

Agilent Technologies Stock Performance

Shares of NYSE A opened at $115.57 on Friday. The stock has a fifty day moving average price of $116.34 and a two-hundred day moving average price of $132.53. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07. The firm has a market cap of $32.66 billion, a P/E ratio of 25.51, a PEG ratio of 2.34 and a beta of 1.30. Agilent Technologies, Inc. has a 1 year low of $104.10 and a 1 year high of $160.27.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 earnings per share for the quarter, missing the consensus estimate of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The business had revenue of $1.80 billion for the quarter, compared to the consensus estimate of $1.81 billion. During the same quarter last year, the business posted $1.31 EPS. The business’s revenue for the quarter was up 7.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Research analysts forecast that Agilent Technologies, Inc. will post 5.95 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st were given a dividend of $0.255 per share. The ex-dividend date was Tuesday, March 31st. This represents a $1.02 annualized dividend and a dividend yield of 0.9%. Agilent Technologies’s dividend payout ratio (DPR) is 22.52%.

Analyst Ratings Changes

Several analysts recently weighed in on the stock. UBS Group cut their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Barclays cut their price objective on shares of Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. HSBC assumed coverage on shares of Agilent Technologies in a research report on Tuesday, January 20th. They issued a “buy” rating and a $180.00 price objective on the stock. TD Cowen lowered their target price on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Finally, Evercore upgraded Agilent Technologies from an “in-line” rating to an “outperform” rating and raised their target price for the company from $155.00 to $160.00 in a research report on Monday, January 5th. Two research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, Agilent Technologies has a consensus rating of “Buy” and a consensus target price of $163.71.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.